Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - INTEREST INCOME & EXPENSE
Interest Income & Expense KPTI - Karyopharm Therapeutics Inc.
23.8 M
LAST VALUE
-4.36%
2 YEAR CAGR
57.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR